Table 2. Univariate and multivariate Cox analysis of the overall survival.
Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | P value | 95% CI | HR | P value | 95% CI | |
RIOK2 | ||||||
Low vs. High | 2.878 | 0.000** | 1.852–4.474 | 2.105 | 0.003* | 1.286–3.445 |
NOB1 | ||||||
Low vs. High | 2.030 | 0.001* | 1.327–3.104 | 1.858 | 0.005* | 1.207–2.862 |
Gender | ||||||
Male vs. Female | 0.715 | 0.124 | 0.467–1.096 | |||
Age, yr | ||||||
<60 vs. ≥60 | 1.099 | 0.662 | 0.719–1.681 | |||
Smoking status | ||||||
No vs. Yes | 1.054 | 0.807 | 0.691–1.607 | |||
Tumour diameter (cm) | ||||||
<3 vs. ≥3 | 1.641 | 0.021* | 1.078–2.502 | |||
TNM clinical stage | ||||||
I and II vs. III | 3.381 | 0.000** | 2.191–5.216 | 2.166 | 0.002* | 1.331–3.524 |
Lymph node metastasis | ||||||
No vs. Yes | 1.795 | 0.010* | 1.148–2.806 | |||
Differentiation | ||||||
Well vs. Moderately vs. Poorly | 2.172 | 0.000** | 1.436–3.286 |
HR, hazard ratio; CI, confidence interval. *P < 0.05, **P < 0.001.